These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24579304)

  • 1. Ex vivo percutaneous absorption of ketamine, bupivacaine, diclofenac, gabapentin, orphenadrine, and pentoxifylline: comparison of versatile cream vs. reference cream.
    Wang X; Black L
    Int J Pharm Compd; 2013; 17(6):520-5. PubMed ID: 24579304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
    Bassani AS; Banov D
    Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro percutaneous absorption of ketoprofen and testosterone: comparison of pluronic lecithin organogel vs. pentravan cream.
    Lehman PA; Raney SG
    Int J Pharm Compd; 2012; 16(3):248-52. PubMed ID: 23050302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Penetration Enhancers on the Percutaneous Delivery of Pain Management Actives.
    Trimble J; Light B
    Int J Pharm Compd; 2016; 20(3):250-256. PubMed ID: 28333667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intestinal absorption mechanism of gabapentin makes it appropriate for gastroretentive delivery.
    Chen C; Cowles VE; Sweeney M
    Curr Clin Pharmacol; 2013 Feb; 8(1):67-72. PubMed ID: 22946876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skin permeation and antinociception of topical gabapentin formulations.
    Bryson E; Asbill S; Sweitzer S
    Int J Pharm Compd; 2014; 18(6):504-11. PubMed ID: 25906628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of gabapentin after a single day and at steady state following the administration of gastric-retentive- extended-release and immediate-release tablets: a randomized, open-label, multiple-dose, three-way crossover, exploratory study in healthy subjects.
    Gordi T; Hou E; Kasichayanula S; Berner B
    Clin Ther; 2008 May; 30(5):909-16. PubMed ID: 18555937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The percutaneous absorption of diclofenac].
    Riess W; Schmid K; Botta L; Kobayashi K; Moppert J; Schneider W; Sioufi A; Strusberg A; Tomasi M
    Arzneimittelforschung; 1986 Jul; 36(7):1092-6. PubMed ID: 3768079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compounded ointment results in severe toxicity in a pediatric patient.
    Sullivan RW; Ryzewski M; Holland MG; Marraffa JM
    Pediatr Emerg Care; 2013 Nov; 29(11):1220-2. PubMed ID: 24196095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Concentrations of Topically Administered Pain Medications.
    Glinn MA; Lickteig AJ; Weber L; Recer S; Salske M; Harvey A; Rappold B; Stensland J; Bell P
    J Anal Toxicol; 2017 Mar; 41(2):127-133. PubMed ID: 28376226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the formulation on the in vitro transdermal penetration of sodium diclofenac. Evaluation of the topical and systemic anti-inflammatory activity in the rat.
    Calpena AC; Escribano E; San Martin H; Lauroba J; Obach R; Domenech J
    Arzneimittelforschung; 1999 Dec; 49(12):1012-7. PubMed ID: 10635447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analgesic Efficacy and Transdermal Penetration of Topical Gabapentin Creams: Finding an Optimal Dose and Pre-treatment Time.
    Heustess A; Spigener S; Sweitzer S; Romero-Sandoval A; Asbill S
    Int J Pharm Compd; 2015; 19(2):167-73. PubMed ID: 26685497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo percutaneous absorption of topical dosage forms: case studies.
    Csóka I; Csányi E; Zapantis G; Nagy E; Fehér-Kiss A; Horváth G; Blazsó G; Eros I
    Int J Pharm; 2005 Mar; 291(1-2):11-9. PubMed ID: 15707727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study on the bioequivalence of two different gabapentin formulations. A randomised, two-period, two-sequence, crossover clinical trial in healthy volunteers.
    Almeida S; Filipe A; Almeida A; Antonijoan R; García-Gea C; Gich I; Barbanoj M; Cruz Caturla M
    Arzneimittelforschung; 2006; 56(2):59-63. PubMed ID: 16572918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation of diclofenac for dermal delivery.
    Goh CF; Lane ME
    Int J Pharm; 2014 Oct; 473(1-2):607-16. PubMed ID: 25091375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of a novel approach for dose individualization in pharmacotherapy using gabapentin in a proof of principles study.
    Blau GE; Orcun S; Laínez JM; Reklaitis GV; Suvannasankha A; Fausel C; Anaissie EJ
    Pharmacotherapy; 2013 Jul; 33(7):727-35. PubMed ID: 23553679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ketamine systemic absorption from topical preparations. Short Communication.
    Zapantis G; Csóka I; Csányi E; Horváth G; Erös I
    Acta Biol Hung; 2006 Sep; 57(3):387-9. PubMed ID: 17048702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermal delivery of desmopressin acetate using colloidal carrier systems.
    Getie M; Wohlrab J; Neubert RH
    J Pharm Pharmacol; 2005 Apr; 57(4):423-7. PubMed ID: 15831201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interchangeability of gabapentin generic formulations in the Netherlands: a comparative bioavailability study.
    Yu Y; Teerenstra S; Vanmolkot F; Neef C; Burger D; Maliepaard M
    Clin Pharmacol Ther; 2013 Oct; 94(4):519-24. PubMed ID: 23708746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.